Event Brief
Oct 14, 2026 at 6:20 PM ET
Moffitt trial tests vaccine to replace breast cancer chemo
By The BriefBrief · Sources (1)
Moffitt Cancer Center in Tampa is testing a custom dendritic cell vaccine made from patients’ blood as an immunotherapy approach for HER2-positive breast cancer without chemotherapy. The trial is accepting patients with stage one or two disease and tumors smaller than three centimeters.
WHO: Moffitt Cancer Center and eligible patients with HER2-positive breast cancer
WHAT: Moffitt Cancer Center is conducting a clinical trial testing a custom dendritic cell vaccine as an immunotherapy treatment without chemotherapy.
WHEN: Reported Oct 14, 2026 at 5:31 PM ET
WHERE: Tampa, Florida
WHY: The trial tests whether a vaccine made from a patient's blood can help the immune system attack cancer cells and improve treatment without chemotherapy.
How this brief is built: The BriefBrief uses multi-source information fusion to correlate reporting across sources, identify related developments, and continuously update a structured WHO, WHAT, WHEN, WHERE and WHY event picture. Pattern arcs, source analysis, and velocity indicators provide deeper analysis in our MI Console.
Hillsborough dengue outbreak prompts mosquito spraying
Dengue
Oct 14, 2026 at 6:20 PM ET
US says it destroyed Iranian-affiliated dhow
Iran
Oct 14, 2026 at 6:10 PM ET
Quaest poll puts Flávio Bolsonaro slightly ahead of Lula
Quaest
Oct 14, 2026 at 6:07 PM ET
Hochul declines apology request during debate
Kathy Hochul
Oct 14, 2026 at 6:05 PM ET
